Triazolam 0.25 MG Oral Tablet — RxCUI 198318
RxNorm drug concept · Semantic clinical drug
RxCUI 198318
Semantic clinical drug · SCD
● Current RxNorm concept 12 FDA products
33 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI198318
Official nameTriazolam 0.25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped12
Package NDCs mapped33
Reported Medicaid activity (SDUD)30,021 prescriptions · 44 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Triazolam: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Triazolam is used for short-term relief of insomnia — trouble falling or staying asleep. It's generally prescribed for just 7 to 10 days. It's not meant to be a long-term sleep sol...
- Take one tablet by mouth right before you get into bed — only when you have a full night ahead of you and don't need to be up and alert within several hours. Don't take it with alc...
- Yes, this is a real concern. Your body can become physically dependent on triazolam, especially if you take it regularly or at higher doses. If you stop suddenly, you can have with...
- The most common ones are drowsiness, dizziness, light-headedness, and headache — basically extensions of how the medicine makes you sleepy. Some people also notice coordination pro...
🕸️ Concept Web — How Triazolam 0.25 MG Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Triazolam 0.25 MG Oral Tablet
RxCUI 198318 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Triazolam
10767IN
-
Triazolam
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Halcion
227423BN
-
Halcion
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Triazolam Oral Tablet
374197SCDF -
Triazolam Oral Product
1158236SCDG -
Triazolam Pill
1158237SCDG -
Triazolam Oral Tablet [Halcion]
369222SBDF -
Halcion Oral Product
1176094SBDG -
Halcion Pill
1176095SBDG -
Oral Tablet
317541DF -
Oral Product
1151131DFG - +1 more in this family
-
Triazolam Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Triazolam 0.25 MG
316856SCDC -
Triazolam 0.25 MG Oral Tablet [Halcion]
208681SBD -
Triazolam 0.25 MG [Halcion]
569344SBDC
-
Triazolam 0.25 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Triazolam 0.25 MG
SCDC · 316856 -
Triazolam Oral Tablet
SCDF · 374197 -
Triazolam Oral Product
SCDG · 1158236 -
Triazolam Pill
SCDG · 1158237
Brand-Name Concepts
-
Triazolam 0.25 MG Oral Tablet [Halcion]
SBD · 208681 -
Triazolam 0.25 MG [Halcion]
SBDC · 569344 -
Triazolam Oral Tablet [Halcion]
SBDF · 369222 -
Halcion Oral Product
SBDG · 1176094 -
Halcion Pill
SBDG · 1176095 -
Halcion
BN · 227423
📦 FDA Products & Package NDCs
12 products · 33 package NDCs
33 package NDCs map to RxCUI 198318 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 43353-0451-30 | 30 TABLET in 1 BOTTLE (43353-451-30) | Triazolam | Aphena Pharma Solutions - Tennessee, LLC | 1982-11-15 |
| 43353-0451-53 | 60 TABLET in 1 BOTTLE (43353-451-53) | Triazolam | Aphena Pharma Solutions - Tennessee, LLC | 1982-11-15 |
| 50090-6471-00 | 30 TABLET in 1 BOTTLE (50090-6471-0) | Triazolam | A-S Medication Solutions | 2023-05-09 |
| 50090-6471-01 | 100 TABLET in 1 BOTTLE (50090-6471-1) | Triazolam | A-S Medication Solutions | 2023-05-09 |
| 50090-7787-00 | 30 TABLET in 1 BOTTLE (50090-7787-0) | Triazolam | A-S Medication Solutions | 2025-11-24 |
| 50090-7787-01 | 100 TABLET in 1 BOTTLE (50090-7787-1) | Triazolam | A-S Medication Solutions | 2025-11-24 |
| 50742-0645-01 | 100 TABLET in 1 BOTTLE, PLASTIC (50742-645-01) | Triazolam | Ingenus Pharmaceuticals, LLC | 2020-10-20 |
| 50742-0646-01 | 100 TABLET in 1 BOTTLE, PLASTIC (50742-646-01) | Triazolam | Ingenus Pharmaceuticals, LLC | 2020-10-20 |
| 50742-0646-05 | 500 TABLET in 1 BOTTLE, PLASTIC (50742-646-05) | Triazolam | Ingenus Pharmaceuticals, LLC | 2020-10-20 |
| 70710-1289-01 | 100 TABLET in 1 BOTTLE (70710-1289-1) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70710-1289-05 | 500 TABLET in 1 BOTTLE (70710-1289-5) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70710-1289-08 | 10 TABLET in 1 BOTTLE (70710-1289-8) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70710-1521-01 | 100 TABLET in 1 BOTTLE (70710-1521-1) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70710-1521-05 | 500 TABLET in 1 BOTTLE (70710-1521-5) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70710-1521-08 | 10 TABLET in 1 BOTTLE (70710-1521-8) | Triazolam | Zydus Pharmaceuticals USA Inc. | 2022-12-30 |
| 70771-1162-01 | 100 TABLET in 1 BOTTLE (70771-1162-1) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 70771-1162-05 | 500 TABLET in 1 BOTTLE (70771-1162-5) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 70771-1162-08 | 10 TABLET in 1 BOTTLE (70771-1162-8) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 70771-1576-01 | 100 TABLET in 1 BOTTLE (70771-1576-1) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 70771-1576-05 | 500 TABLET in 1 BOTTLE (70771-1576-5) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 70771-1576-08 | 10 TABLET in 1 BOTTLE (70771-1576-8) | Triazolam | Zydus Lifesciences Limited | 2022-12-30 |
| 71335-1876-00 | 3 TABLET in 1 BOTTLE, PLASTIC (71335-1876-0) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-01 | 10 TABLET in 1 BOTTLE, PLASTIC (71335-1876-1) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-02 | 30 TABLET in 1 BOTTLE, PLASTIC (71335-1876-2) | Triazolam | Bryant Ranch Prepack | 2021-06-08 |
| 71335-1876-03 | 60 TABLET in 1 BOTTLE, PLASTIC (71335-1876-3) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-04 | 40 TABLET in 1 BOTTLE, PLASTIC (71335-1876-4) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-05 | 90 TABLET in 1 BOTTLE, PLASTIC (71335-1876-5) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-06 | 6 TABLET in 1 BOTTLE, PLASTIC (71335-1876-6) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 71335-1876-07 | 1 TABLET in 1 BOTTLE, PLASTIC (71335-1876-7) | Triazolam | Bryant Ranch Prepack | 2021-12-03 |
| 71335-1876-08 | 2 TABLET in 1 BOTTLE, PLASTIC (71335-1876-8) | Triazolam | Bryant Ranch Prepack | 2021-09-07 |
| 71335-1876-09 | 28 TABLET in 1 BOTTLE, PLASTIC (71335-1876-9) | Triazolam | Bryant Ranch Prepack | 2021-12-29 |
| 72789-0349-30 | 30 TABLET in 1 BOTTLE, PLASTIC (72789-349-30) | Triazolam | PD-Rx Pharmaceuticals, Inc. | 2023-08-17 |
| 82804-0275-30 | 30 TABLET in 1 BOTTLE, PLASTIC (82804-275-30) | Triazolam | Proficient Rx LP | 2020-10-20 |
Observed labelers:
Bryant Ranch Prepack (10) ·
Zydus Lifesciences Limited (6) ·
Zydus Pharmaceuticals USA Inc. (6) ·
A-S Medication Solutions (4) ·
Ingenus Pharmaceuticals, LLC (3) ·
Aphena Pharma Solutions - Tennessee, LLC (2)
· +2 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.